Efficacy of non-invasive treatment options for single-sided deafness: A prospective study of 20 patients.

Efficacy of non-invasive treatment options for single-sided deafness: A prospective study of 20 patients.:

Related Articles

Efficacy of non-invasive treatment options for single-sided deafness: A prospective study of 20 patients.

Clin Otolaryngol. 2020 Jan 20;:

Authors: Cho YS, Park YK, Seol HY, Lim JH, Hong SH, Moon IJ

Abstract

We aimed to ascertain which of the following devices will perform better for individuals with single-sided deafness (SSD): non-invasive contralateral routing of signal (CROS) hearing aid (HA) and the new type of bone conduction devices (BCDs) which include ADHEAR and SoundArc. A CROS hearing aid provided some advantage for speech perception in a noisy environment when target speech was directed to the impaired ear side. However, it also showed an adverse effect when the noise was presented to the better ear. Neither of the adhesive-type BCDs (ADHEAR or SoundArc), showed pseudobinaural benefits in the Hearing in Noise Test (HINT). Sound localization ability was not significantly affected by any device. However, all devices significantly reduced listening effort in noise conditions Although there was little enhancement in speech perception in noise with CROS, and the new type of BCDs, all devices significantly reduced listening effort.

PMID: 31960601 [PubMed - as supplied by publisher]